Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.38 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199863 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL103129 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL99731 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL202269 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL102015 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL103377 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL201336 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL202134 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL100621 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR | |
| SCHEMBL101056 | 1.00 | LMNA (0.54) | LMNADNM1ALDH1A1TDP1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3676240-B1 | ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-11-01 | — | — | EP | claimed |
| CN-110637023-B | Dibenzopyrrole methine boron chelate compound, near infrared light absorbing material, thin film, and organic electronic device | 日本化药株式会社 | 2022-07-08 | — | — | CN | claimed |
| US-10662388-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-05-26 | — | — | US | claimed |
| CN-118201905-A | Cationic lipid | 武田药品工业株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-117136206-A | Aqueous polyurethane and polyurethane/poly (meth) acrylate hybrid dispersions | 巴斯夫欧洲公司 | 2023-11-28 | — | — | CN | disclosed |
| EP-3676240-B1 | ESTER COMPOUNDS AND LUBRICATING OIL COMPOSITIONS CONTAINING SAME | EXXONMOBIL CHEMICAL PATENTS INC (US) | 2023-11-01 | — | — | EP | disclosed |
| EP-3666777-B1 | DIBENZOPYRROMETHENE BORON CHELATE COMPOUND, NEAR-INFRARED LIGHT-ABSORBING MATERIAL, THIN-FILM, AND ORGANIC ELECTRONIC DEVICE | NIPPON KAYAKU KK (JP) | 2023-10-11 | — | — | EP | disclosed |
| WO-2023135035-A1 | METHOD FOR THE MANUFACTURE OR CONVERSION OF ALKANOLAMINES | BASF SE (DE) | 2023-07-20 | — | — | WO | disclosed |
| CN-110073507-B | Organic semiconductor composition, organic thin film, and organic thin film transistor | 日本化药株式会社 | 2023-07-04 | — | — | CN | disclosed |
| CN-116323737-A | Aqueous self-crosslinkable polyurethane dispersions | 巴斯夫欧洲公司 | 2023-06-23 | — | — | CN | disclosed |
| WO-2023085299-A1 | CATIONIC LIPID | 武田薬品工業株式会社 | 2023-05-19 | — | — | WO | disclosed |
| US-5530127-A | AMINATION OF PRIMARY OR SECONDARY ALCOHOL IN PRESENCE OF ZIRCONIUM/COPPER/NICKEL OXIDE CATALYST, ALSO CONTAINING MOLYBDENUM AND POSSIBLE ALUMINUM AND MANGANESE | BASF AKTIENGESELLSCHAFT (DE) | 1996-06-25 | — | — | US | disclosed |
| EP-0696572-A1 | Process for the preparation of amines | BASF AKTIENGESELLSCHAFT (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0691157-A1 | Copper oxide and zirconium oxide containing catalyst | BASF Aktiengesellschaft (DE) | 1996-01-10 | — | — | EP | disclosed |
| US-5463130-A | Preparation of peralkylated amines | BASF AKTIENGESELLSCHAFT (DE) | 1995-10-31 | — | — | US | disclosed |
| EP-0673918-A1 | Process for the preparation of peralkylated amines | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-27 | — | — | EP | disclosed |
| US-4810710-A | SEROTONIN BLOCKERS | ELI LILLY AND COMPANY (US) | 1989-03-07 | — | — | US | disclosed |
| US-4762842-A | SEROTONIN ANTAGONIST | ELI LILLY AND COMPANY (US) | 1988-08-09 | — | — | US | disclosed |
| US-4713384-A | HYPOTENSIVE AND ANTIMIGRAINE AGENTS | ELI LILLY AND COMPANY (US) | 1987-12-15 | — | — | US | disclosed |
| EP-0218433-A1 | Selective method for blocking 5HT2 receptors | ELI LILLY AND COMPANY (US) | 1987-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662388-B2 | Ester compounds, lubricating oil compositions containing same and processes for making same | GK, NOTUM, EBP | LMNA 2637/4885DNM1 2273/4885ALDH1A1 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.